Mutation in ACTC1 and TTN Linked to Infant Heart Disease
Author Information
Author(s): Jose G. Acuña-Ochoa, Norma A. Balderrábano-Saucedo, Ana C. Cepeda-Nieto, Maria Y. Alvarado-Cervantes, Vianca L. Ibarra-Garcia, Daniel Barr, Matthew J. Gage, Ryan Pfeiffer, Dan Hu, Hector Barajas-Martinez
Primary Institution: Lankenau Institute for Medical Research
Hypothesis
Can specific genetic mutations in ACTC1 and TTN cause severe dilated cardiomyopathy in infants?
Conclusion
The study suggests that a de novo mutation in ACTC1, along with a TTN variant, may lead to severe dilated cardiomyopathy and premature death in infants.
Supporting Evidence
- Genetic screening identified two deleterious mutations in the patient.
- The ACTC1 mutation was not found in any first-degree relatives.
- Computational modeling showed structural changes in the mutated proteins.
- The patient presented severe left ventricular dilation and dysfunction.
- Next generation sequencing provided high-quality data for variant analysis.
- Both mutations were located in well-conserved regions of their respective proteins.
- The study highlights the importance of genetic testing in severe cardiomyopathies.
- De novo mutations are significant in the etiology of genetic diseases.
Takeaway
A baby had a serious heart problem because of two genetic changes, one of which was new and not inherited from parents.
Methodology
Next generation sequencing was used to analyze 132 genes related to cardiac function in the patient and family members.
Limitations
The study may not account for other genetic or environmental factors influencing dilated cardiomyopathy.
Participant Demographics
One-year-old Mexican male infant.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website